#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	16042	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2100	758.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1443	1443	C	919	C	854	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	16042	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2100	758.2	0	HET	.	.	.	C207T,G,A	.	207	207	C	466	466	C	882	C,T,G,A	654,165,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29406	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3350	870.0	0	.	n	.	0	T695C	SNP	695	695	T	909	909	C	882	C,T	816,3	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29406	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3350	870.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2185	2185	C	944	C,T	863,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29406	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3350	870.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2259	2259	A	943	A	896	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29406	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3350	870.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	2811	2811	C	902	C	840	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29406	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3350	870.0	0	HET	.	.	.	A1638G	.	1638	1638	A	1852	1852	A	929	A,G	503,371	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	2088	folP	855	855	100.0	folP.l15.c30.ctg.1	1717	121.4	1	SNP	p	R229S	1	.	.	685	687	AGC	1137	1139	AGC	187;185;185	A;G;C	172;174;166	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5620	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3385	165.4	1	SNP	p	S91F	1	.	.	271	273	TTC	553	555	TTC	183;181;179	T;T;C	170;169;168	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5620	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3385	165.4	1	SNP	p	G95N	0	.	.	283	285	GGC	565	567	GGC	180;174;176	G;G;C	170;165;164	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5620	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3385	165.4	1	SNP	p	D95G	1	.	.	283	285	GGC	565	567	GGC	180;174;176	G;G;C	170;165;164	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	1678	mtrR	633	633	100.0	mtrR.l6.c30.ctg.1	1315	127.1	1	SNP	p	G45D	0	.	.	133	135	GGC	479	481	GGC	206;205;201	G;G;C	188;185;183	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	880	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1090	80.3	0	.	n	.	0	A197.	DEL	197	197	A	582	582	A	221	A	204	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6242	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2941	211.2	1	SNP	p	D86N	0	.	.	256	258	GAC	599	601	GAC	258;260;263	G;A;C	240;234;242	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6242	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2941	211.2	1	SNP	p	S87R	1	.	.	259	261	CGT	602	604	CGT	263;263;260	C,A;G;T,A	243,1;241;236,1	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6242	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2941	211.2	1	SNP	p	R87W	0	.	.	259	261	CGT	602	604	CGT	263;263;260	C,A;G;T,A	243,1;241;236,1	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6242	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2941	211.2	1	SNP	p	R87I	0	.	.	259	261	CGT	602	604	CGT	263;263;260	C,A;G;T,A	243,1;241;236,1	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6242	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2941	211.2	1	SNP	p	S88P	0	.	.	262	264	TCC	605	607	TCC	258;257;257	T;C;C	230;237;237	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4580	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2689	169.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1550	1552	GGC	250;247;246	G;G;C	228;225;224	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4262	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2464	172.4	1	SNP	p	A311V	0	.	.	931	933	GCC	1336	1338	GCC	228;227;226	G;C;C	211;211;208	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4262	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2464	172.4	1	SNP	p	I312M	1	.	.	934	936	ATG	1339	1341	ATG	225;223;223	A;T;G	211;207;208	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4262	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2464	172.4	1	SNP	p	V316T	1	.	.	946	948	ACC	1351	1353	ACC	220;221;220	A;C;C	199;204;202	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4262	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2464	172.4	1	SNP	p	T316P	0	.	.	946	948	ACC	1351	1353	ACC	220;221;220	A;C;C	199;204;202	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4262	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2464	172.4	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1852	1854	ACC	220;221;221	A;C,T;C	204;211,1;213	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4262	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2464	172.4	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1906	1908	GCG	234;230;233	G;C;G	222;218;222	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4262	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2464	172.4	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1906	1908	GCG	234;230;233	G;C;G	222;218;222	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4262	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2464	172.4	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2029	2031	GGT	182;182;181	G;G,T;T	163;161,1;157	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4262	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2464	172.4	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2038	2040	AGC	177;174;173	A;G;C	156;153;152	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4262	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2464	172.4	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2056	2058	CCG	159;161;157	C,G;C,G;G	120,6;127,1;122	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6316	ponA	2397	2397	100.0	ponA.l6.c30.ctg.1	3179	198.2	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1659	1661	CCG	222;226;223	C,A;C;G,A,C	187,1;204;194,1,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2540	porA	1146	1146	99.91	porA.l6.c4.ctg.1	2023	124.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	674	674	C	171	C	159	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2864	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1507	188.2	1	SNP	p	G120K	1	.	.	358	360	AAG	642	644	AAG	229;231;230	A;A;G	218;222;219	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2864	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1507	188.2	1	SNP	p	N121D	0	.	.	361	363	AAC	645	647	AAC	233;230;232	A;A;C	222;219;219	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2864	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1507	188.2	1	SNP	p	A121N	1	.	.	361	363	AAC	645	647	AAC	233;230;232	A;A;C	222;219;219	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10952	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4949	220.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1132	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1173	96.1	1	SNP	p	V57M	1	.	.	169	171	ATG	585	587	ATG	233;233;233	A;T,C;G	223;221,1;220	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
